Related references
Note: Only part of the references are listed.Recent insights into the mode of action of memantine and ketamine
Jon W. Johnson et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Differential Modulation of Reinforcement Learning by D2 Dopamine and NMDA Glutamate Receptor Antagonism
Gerhard Jocham et al.
JOURNAL OF NEUROSCIENCE (2014)
Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS
Neal R. Swerdlow et al.
SCHIZOPHRENIA RESEARCH (2014)
Disentangling early sensory information processing deficits in schizophrenia
Anthony J. Rissling et al.
CLINICAL NEUROPHYSIOLOGY (2012)
Beyond Antipsychotics: Pharmacologically-Augmented Cognitive Therapies (PACTs) for Schizophrenia
Neal R. Swerdlow
NEUROPSYCHOPHARMACOLOGY (2012)
Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
Daniel C. Javitt et al.
SCHIZOPHRENIA BULLETIN (2012)
Twenty-five Years of Glutamate in Schizophrenia: Are We There Yet?
Daniel C. Javitt
SCHIZOPHRENIA BULLETIN (2012)
Prediction of Psychosis by Mismatch Negativity
Mitja Bodatsch et al.
BIOLOGICAL PSYCHIATRY (2011)
Memantine Prevents Hypoglycemia-Induced Decrements of the Cerebral Energy Status in Healthy Subjects
B. Willenborg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Acute Stress Alters Auditory Selective Attention in Humans Independent of HPA: A Study of Evoked Potentials
Ludger Elling et al.
PLOS ONE (2011)
Are we studying and treating schizophrenia correctly?
Neal R. Swerdlow
SCHIZOPHRENIA RESEARCH (2011)
Changes in cerebral glucose metabolism in patients with posttraumatic cognitive impairment after memantine therapy: a preliminary study
Yong Wook Kim et al.
ANNALS OF NUCLEAR MEDICINE (2010)
Improvement of Negative and Positive Symptoms in Treatment-Refractory Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial With Memantine as Add-On Therapy to Clozapine
David de Lucena et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
A Randomized, Placebo-Controlled Study of Memantine as Adjunctive Treatment in Patients with Schizophrenia
Jeffrey A. Lieberman et al.
NEUROPSYCHOPHARMACOLOGY (2009)
The Effects of Memantine on Prepulse Inhibition
N. R. Swerdlow et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry
Ming-Yan Liu et al.
CLINICAL THERAPEUTICS (2008)
Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: A preliminary study
Amir Krivoy et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
A systematic review of off-label uses of memantine for psychiatric disorders
Kristina Zdanys et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Realistic expectations of prepulse inhibition in translational models for schizophrenia research
Neal R. Swerdlow et al.
PSYCHOPHARMACOLOGY (2008)
Memantine agonist action at dopamine D2High receptors
Philip Seeman et al.
SYNAPSE (2008)
Preattentive sensory processing as indexed by the MMN and P3a brain responses is associated with cognitive and psychosocial functioning in healthy adults
Gregory A. Light et al.
JOURNAL OF COGNITIVE NEUROSCIENCE (2007)
Phonetic mismatch negativity predicts social skills acquisition in schizophrenia
Yuki Kawakubo et al.
PSYCHIATRY RESEARCH (2007)
Effects of NMDA receptor antagonist memantine on mismatch negativity
Milena Korostenskaja et al.
BRAIN RESEARCH BULLETIN (2007)
Startle gating deficits in a large cohort of patients with schizophrenia - Relationship to medications, symptoms, neurocognition, and level of function
Neal R. Swerdlow et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Clozapine enhances prepulse inhibition in healthy humans with low but not with high prepulse inhibition levels
Franz X. Vollenweider et al.
BIOLOGICAL PSYCHIATRY (2006)
Antipsychotic effects on prepulse inhibition in normal 'low gating' humans and rats
Neal R. Swerdlow et al.
NEUROPSYCHOPHARMACOLOGY (2006)
The level of prepulse inhibition in healthy individuals may index cortical modulation of early information processing
SG Giakoumaki et al.
BRAIN RESEARCH (2006)
Increased prepulse inhibition of the acoustic startle response is associated with better strategy formation and execution times in healthy males
Panos Bitsios et al.
NEUROPSYCHOLOGIA (2006)
Stability of mismatch negativity deficits and their relationship to functional impairments in chronic schizophrenia
GA Light et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Impaired mismatch negativity generation in prodromal subjects and patients with schizophrenia
A Brockhaus-Dumke et al.
SCHIZOPHRENIA RESEARCH (2005)
Dementia of Alzheimer's disease and other neurodegenerative disorders - memantine, a new hope
SK Sonkusare et al.
PHARMACOLOGICAL RESEARCH (2005)
Low dose ketamine increases prepulse inhibition in healthy men
KM Abel et al.
NEUROPHARMACOLOGY (2003)
A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)
G Wilcock et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2002)
Effects of amantadine and bromocriptine on startle and sensorimotor gating: parametric studies and cross-species comparisons
NR Swerdlow et al.
PSYCHOPHARMACOLOGY (2002)
Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies
NR Swerdlow et al.
PSYCHOPHARMACOLOGY (2002)
Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers
D Umbricht et al.
BIOLOGICAL PSYCHIATRY (2002)
Clinical and sensorimotor gating effects of ketamine in normals
EJ Duncan et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Comparison of the effects of ketamine and memantine on prolactin and cortisol release in men: A randomized, double-blind, placebo-controlled trial
N Hergovich et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers -: Implications for models of cognitive deficits in schizophrenia
D Umbricht et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Effects of caffeine on sensorimotor gating of the startle reflex in normal control subjects: impact of caffeine intake and withdrawal
NR Swerdlow et al.
PSYCHOPHARMACOLOGY (2000)
Share Paper
